Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy-Reference-Cited by-同舟云学术

Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy

Published:2015-10-23 Issue:21 Volume:85 Page:1886-1893
ISSN:0028-3878
Container-title:Neurology
language:en
Short-container-title:Neurology

Author:

Peverelli Lorenzo,Testolin Silvia,Villa Luisa,D'Amico Adele,Petrini Stefania,Favero Chiara,Magri Francesca,Morandi Lucia,Mora Marina,Mongini Tiziana,Bertini Enrico,Sciacco Monica,Comi Giacomo P.,Moggio Maurizio

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical)

Reference35 articles.

1. Eteplirsen for the treatment of Duchenne muscular dystrophy

2. Novel Approaches to Corticosteroid Treatment in Duchenne Muscular Dystrophy

3. Phase 2a Study of Ataluren-Mediated Dystrophin Production in Patients with Nonsense Mutation Duchenne Muscular Dystrophy

4. Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

5. Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current Challenges of Using Patient-Level Claims and Electronic Health Record Data for the Longitudinal Evaluation of Duchenne Muscular Dystrophy Outcomes;Advances in Therapy;2024-07-30

2. Pharmacological Treatments and Therapeutic Targets in Muscle Dystrophies Generated by Alterations in Dystrophin-Associated Proteins;Medicina;2024-06-27

3. A qualitative study to understand the Duchenne muscular dystrophy experience from the parent/patient perspective;Journal of Patient-Reported Outcomes;2023-12-12

4. Myopathologic trajectory in Duchenne muscular dystrophy (DMD) reveals lack of regeneration due to senescence in satellite cells;Acta Neuropathologica Communications;2023-10-19

5. Evolving Therapeutic Options for the Treatment of Duchenne Muscular Dystrophy;Neurotherapeutics;2023-10